RecruitingNCT07273695

Assessing Real Life Effectiveness of Treatment in Neurodevelopmental Disorders

Observational studyAges 8–15ItalyADHD

The study in practice

Understand this study

Listed age limits: 8 years to 15 years.

Listed locations: Bosisio Parini, ItalySee all locations and recruitment
Activities: Medication exposure observed; not assigned by the study · Behavioural activities described in the protocol
Compensation: Payment and expense reimbursement have not been verified.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: September 19, 2025

Recruitment status: Recruiting
Enrollment listed in the registry: 80
Sponsor: IRCCS Eugenio Medea
Sponsor type: Unknown or unclear
Study type: Observational
Intervention type: Psychotherapy / behavioral intervention, Medication / drug
Study phase: Not clearly listed
Locations: Italy
Age range: From 8 Years to 15 Years
Official registry ID: NCT07273695
Official title: Show the full official title
Assessing Real Life Effectiveness of Treatment in Neurodevelopmental Disorders

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Recruiting

Bosisio Parini

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is IRCCS Eugenio Medea.

Does this study involve medication?

Yes. The study involves medication, including methyphenidate.

Who can participate?

Listed age limits: 8 years to 15 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.